- Home
- CDXS vs IMPP Comparison
CDXS vs IMPP Comparison
Compare CDXS & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- IMPP
- Stock Information
- Founded
- CDXS 2002
- IMPP 1981
- Country
- CDXS United States
- IMPP Greece
- Employees
- CDXS N/A
- IMPP N/A
- Industry
- CDXS Major Chemicals
- IMPP Marine Transportation
- Sector
- CDXS Industrials
- IMPP Consumer Discretionary
- Exchange
- CDXS Nasdaq
- IMPP Nasdaq
- Market Cap
- CDXS 216.6M
- IMPP 174.2M
- IPO Year
- CDXS 2010
- IMPP N/A
- Fundamental
- Price
- CDXS $2.65
- IMPP $4.39
- Analyst Decision
- CDXS Buy
- IMPP Strong Buy
- Analyst Count
- CDXS 2
- IMPP 1
- Target Price
- CDXS $11.00
- IMPP $5.50
- AVG Volume (30 Days)
- CDXS 542.5K
- IMPP 339.6K
- Earning Date
- CDXS 10-30-2025
- IMPP 12-01-2025
- Dividend Yield
- CDXS N/A
- IMPP N/A
- EPS Growth
- CDXS N/A
- IMPP N/A
- EPS
- CDXS N/A
- IMPP 1.02
- Revenue
- CDXS $57,164,000.00
- IMPP $127,675,263.00
- Revenue This Year
- CDXS $12.88
- IMPP $9.69
- Revenue Next Year
- CDXS $21.64
- IMPP $51.33
- P/E Ratio
- CDXS N/A
- IMPP $4.32
- Revenue Growth
- CDXS N/A
- IMPP N/A
- 52 Week Low
- CDXS $1.90
- IMPP $2.12
- 52 Week High
- CDXS $6.08
- IMPP $5.25
- Technical
- Relative Strength Index (RSI)
- CDXS 55.26
- IMPP 46.79
- Support Level
- CDXS $2.46
- IMPP $4.27
- Resistance Level
- CDXS $2.76
- IMPP $4.79
- Average True Range (ATR)
- CDXS 0.16
- IMPP 0.25
- MACD
- CDXS 0.02
- IMPP -0.09
- Stochastic Oscillator
- CDXS 50.97
- IMPP 12.75
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.